On 23 August 2017, orphan designation (EU/3/17/1907) was granted by the European Commission to Trimunocor Ltd, United Kingdom, for recombinant fragment of human surfactant protein-D for the prevention of bronchopulmonary dysplasia.
The sponsorship was transferred to Premier Research Group S.L., Spain, in August 2019.
Recombinant fragment of human surfactant protein-D
|Disease / condition||
Prevention of bronchopulmonary dysplasia
|Date of first decision||
|EU designation number||
Review of designation
Sponsor's contact details
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.
Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.